Gener8tor & BioReact
A Zero-Equity Accelerator Purpose-Built for Biotech
BioReact’s mission to streamline bioprocess R&D just received a major boost: we’ve been accepted into the Spring 2024 gBETA Life Sciences cohort powered by Gener8tor and headed by Program Manager Camilo Lozano. The competitive, seven-week accelerator will equip our team with deep industry mentorship, investor exposure, and the resources to scale our AI-driven fermentation software faster than ever. techpoint.orggener8tor.com
gBETA Life Sciences is a free, no-equity program that selects up to five early-stage startups per cohort. Over seven intensive weeks, founders receive individualized coaching on product-market fit, fundraising strategy, and go-to-market execution—culminating in a high-profile pitch night. grantexec.com
Leadership by Camilo Lozano
As Program Manager for both gBETA Life Sciences and gBETA Agbioscience, Camilo Lozano brings a robust network across pharma, med-tech, and industrial biotech—making him an ideal mentor for BioReact’s growth journey. gener8tor.com
Why Acceptance Matters for BioReact
Weekly “Mentor Swarms” will pair our team with scientists, operators, and investors who understand the pain of siloed bioprocess data. Their feedback will refine key modules—data visualization, experiment management, and built-in statistics—ensuring we solve the most urgent lab challenges.
Investor & Corporate Connectivity
gBETA’s nationwide network spans more than 6,000 mentors and 1,000 alumni companies. Access to this community, plus an invite-only pitch night, will accelerate introductions to venture funds and potential enterprise customers.
Accelerated Roadmap Execution
With structured KPI tracking each week, we’ll push faster on upcoming releases, including our strain-engineering analytics and scale-up simulation tools, while tightening SOC 2-ready security for enterprise deployments.
How gBETA Accelerates Our Vision
Guidance from gBETA mentors will inform user-requested upgrades—automated DOE templates, richer multi-omics support, and collaboration controls—for our free tier (up to ten experiments).
Strengthening Commercial Strategy
Sales coaches will help optimize our pricing model and channel partnerships, aligning with our goal of reaching $500 K ARR while keeping a product-led growth motion.
Fundraising Readiness
Office hours with legal and finance experts will prime BioReact for its next seed round, sharpening narratives on market size, defensible tech, and scalable revenue paths.
Fueling the Future of Bioprocess Innovation
Joining Gener8tor’s Spring 2024 gBETA Life Sciences cohort validates our vision of an integrated, AI-ready lab ecosystem. With Camilo Lozano’s leadership and gBETA’s resources, we’ll accelerate product development, deepen industry ties, and drive our mission: empowering scientists with a single platform that replaces fragmented software stacks and speeds sustainable bioproducts to market. Stay tuned for updates as we sprint through the program and continue transforming fermentation R&D!